As cancer rates continue to surge globally, the impact on women is becoming increasingly severe. And, nowhere is this more evident than in Asia Pacific, which accounts for a staggering 45% of all global breast cancer cases and 58% of cervical cancer deaths worldwide.

Yet, we know that tools exist to eliminate cervical cancer as a public health problem and to reduce the incidence of breast cancer. So why is it that in the Asia-Pacific region in particular, incidence and mortality are not decreasing?

Ahead of International Women’s Day 2024, Amy Ho, Head of Disease Areas for Roche Diagnostics APAC, member of Roche’s International Women’s Network  and of the Asia-Pacific Women's Cancer Coalition weighs in.